MyOme Raises $23M in Series B Funding
- MyOme, a Menlo Park, CA-based clinical whole genome platform analysis company, raised $23m in Series B financing
- The round, which brought the total raised to over $36M, was led by Healthcare Venture Partners
- The company intends to use the funds to begin commercialization of its clinical whole genome analysis platform technology and clinical reports to health systems
- The company is a clinical whole genome analysis platform company allowing families to understand their risk for inherited diseases
- It is certified under the Clinical Laboratory Improvement Amendments (CLIA)
